Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04293146

Pre- Versus Sub-pectoral Implant-based Breast Reconstruction After Skin-sparing Mastectomy or Nipple-sparing Mastectomy OPBC-02PREPEC

This trial is to investigate whether pre-pectoral Implant-Based Breast Reconstruction (IBBR) provides better Quality of Life (QoL) with respect to long-term (24 months) physical well-being (chest) compared to sub-pectoral IBBR for patients undergoing skin-sparing mastectomy or nipple-sparing mastectomy for prevention or treatment of breast cancer.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Universitätsklinik für Frauenheilkunde und Geburtshilfe, Salzburg, Austria

Loading trial locations.

About this study

This trial is to investigate whether pre-pectoral Implant-Based Breast Reconstruction (IBBR) provides better Quality of Life (QoL) with respect to long-term (24 months) physical well-being (chest) compared to sub-pectoral IBBR for patients undergoing skin-sparing mastectomy or nipple-sparing mastectomy for prevention or treatment of breast cancer.The aim is to adhere to standard of care as much as possible to follow the pragmatic trial design to generate data that are applicable to today's practice. Therefore, surgeons are allowed to use their preferred Acellular Dermal Matrix (ADM), synthetic meshes, expanders and implants, thereby offering practitioners considerable leeway in deciding how to perform the procedure. For the same reason, both the one- and two-staged IBBR approaches are allowed when studying pre- versus sub-pectoral IBBR.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Written informed consent according to ICH/GCP regulations prior to any trial specific procedures
  • Patients undergoing NSM or SSM and IBBR in the therapeutic or risk-reducing Setting
  • Ability to complete the Quality of Life questionnaires

Exclusion criteria

  • No indication for IBBR according to clinical judgment of the treating surgeon
  • Skin flaps inadequate for pre-pectoral IBBR.

Treatment and study plan

pre-pectoral IBBR

Procedure

The breast is reconstructed by positioning a breast implant above (pre-pectoral) the pectoralis major muscle.

sub-pectoral IBBR

Procedure

The breast is reconstructed by positioning a breast implant below (sub-pectoral) the pectoralis major muscle.

Primary outcomes

  1. Change in BREAST-Q scale

    Time frame: within 24 months after mastectomy (screening, day 10, and months 1, 6, 12 and 24)

    compare the Quality of Life (QoL) with respect to long-term physical well-being (chest) after pre-pectoral or sub-pectoral IBBR. The BREAST-Q module specific to breast reconstruction version 2.0 consists of 13 independent scales covering health-related QoL domains and satisfaction domains. Each scale is scored to generate a numerical score on a scale from 0 (worst) to 100 (best).

  2. Change in EQ-5D-5L questionnaire

    Time frame: within 24 months after mastectomy (screening, day 10, and months 1, 6, 12 and 24)

    The 5-level version of the EQ-5D (EQ-5D-5L) consists of the EQ-5D descriptive system that comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/Depression (5 answer levels each: no problems, slight problems, moderate problems, severe problems and extreme problems), resulting in a 1-digit number that expresses the level for that dimension. The digits for each dimension are combined into a 5-digit number that describes the patient's health state and is subsequently converted into a preference-based quality of life weight (utility) using an algorithm derived from population-based studies. In addition, patients are asked to rate their health on a vertical visual analogue scale (EQ VAS), where the anchors are labelled with 'The best health you can imagine' and 'The worst health you can imagine'.

Secondary outcomes

  1. loss of expander or implant

    Time frame: within 24 months of undergoing mastectomy and immediate reconstruction

    compare the safety of pre-pectoral and sub-pectoral IBBR, in terms of loss of expander or implant. Loss of expander or implant is defined as an unplanned surgical removal of expander/implant with or without immediate replacement.

  2. surgical complications

    Time frame: within 24 months of undergoing mastectomy and immediate reconstruction

    compare the safety of pre-pectoral and sub-pectoral IBBR, in terms of surgical complications. The complications include: Wound dehiscence, Haematoma, Seroma, Implant/expander exposure/Extrusion, Implant/Expander rotation/malpositioning, Infection, Mastectomy skin flap necrosis, Capsular contraction, Lymphedema

  3. thromboembolic events

    Time frame: within 24 months of undergoing mastectomy and immediate reconstruction

    compare the safety of pre-pectoral and sub-pectoral IBBR, in terms of thromboembolic events according to Common Terminology Criteria for Adverse Events (CTCAE) v5.0

  4. patient satisfaction

    Time frame: over 24 months since mastectomy

    compare patient satisfaction after pre-pectoral or sub-pectoral IBBR

  5. animation deformity

    Time frame: before and 24 months after the mastectomy

    compare animation deformity after pre-pectoral or sub-pectoral IBBR by using pictures from before and 24 months after the mastectomy

  6. capsular contracture

    Time frame: before and 24 months after the mastectomy

    compare capsular contracture after pre-pectoral or sub-pectoral IBBR by using pictures from before and 24 months after the mastectomy

  7. aesthetic results

    Time frame: before and 24 months after the mastectomy

    compare aesthetic results after pre-pectoral or sub-pectoral IBBR assessed by photographs of the breast taken in a standardized way. They will be evaluated by an experienced investigator who is blinded for group assignment. The blinded outcome assessment team will be trained to enter data for the two most widely used semi-automatic software for objective aesthetic evaluation, the 'Breast Cancer Conservative Treatment cosmetic results' (BCCT.core)

  8. Recurrence-free survival (RFS)

    Time frame: until 10 years after mastectomy and IBBR.

    RFS is defined as the time from randomization until the first documentation of any of the following events: local-regional occurrence or recurrence of invasive disease or ductal carcinoma in situ (DCIS), distant breast cancer metastasis, or death from any cause.

  9. aesthetic results evaluated by patients

    Time frame: at baseline and after 24 months

    evaluated by patients using a four point scale: excellent, good, regular, bad.

  10. total number of operative procedures

    Time frame: until 24 months after mastectomy

    assess the burden on patients by total number of operative procedures

  11. length of hospital stay (index hospitalization and overall)

    Time frame: until 24 months after randomization

    length of hospital stay (index hospitalization and overall) following randomization until discharge and the cumulative number of days the patient was hospitalized

  12. total number of outpatient visits at the trial site and the emergency department

    Time frame: from admission for mastectomy until 24 months after randomization

    assess the burden on patients by total number of outpatient visits at the trial site and the emergency department

  13. aesthetic results evaluated by local physicians

    Time frame: at baseline and after 24 months

    evaluated by local physicians using a four point scale: excellent, good, regular, bad.

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Collaborators

  • Swiss National Science Foundation

Registry information

Official study title

Pre- Versus Sub-pectoral Implant-based Breast Reconstruction After Skin-sparing Mastectomy or Nipple-sparing Mastectomy (OPBC-02/ PREPEC): a Pragmatic, Multicenter, Randomized, Superiority Trial

Acronym: OPBC-02PREPEC

Important dates

Study start
2020
Primary completion
2025
Study completion
2033
First posted
Mar 3, 2020
Registry last updated
Dec 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.